- €75.66m
- €133.26m
- €852.60m
Euroapi plummets after outlook cut, mid-term guidance withrawal
Brief: Euroapi Full-Year 2023 Outlook Revised Downwards
Brief: Euroapi To Acquire BianoGMP For Eur 10 Mln
Euroapi tracks best day ever after H1 EBITDA beat, revenue outlook reiteration
Brief: EuroAPI H1 Sales at EUR 496.6 Million
Brief: Euroapi Cuts FY Core EBITDA Margin Outlook
Brief: Euroapi Plans To Invest In R&D Projects To Support Supply Of Essential Medicines To France, Europe
Brief: Euroapi To Invest €50 Million At Its Budapest Site To Meet The Growing Demand For Prostaglandins
Brief: Euroapi Signs CDMO Agreement With Novéal To Advance Cosmetic Projects
Berenberg initiates 'well positioned' EUROAPI with 'buy'
Europe Research Roundup: Givaudan, National Grid Plc, Teamviewer
Euroapi heads for worst day ever as outlook disappoints
Brief: Euroapi FY Operating Loss Narrows To 0.8 Million Euros
Brief: Euroapi: Progressive Restart Of Prostaglandin Production At Budapest Site
Brief: Euroapi To Invest Eur 40 Mln To Improve Production Process In France
Euroapi plummets on profit warning after prostaglandin production suspension
Brief: Euroapi Sees Net Sales Reaching Circa EUR 980 Mln In 2022
French and Benelux stocks-Factors to watch
Euroapi rises on Frankfurt site capacity increase plan